These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16721109)

  • 1. Prenatal therapy for fetal growth restriction.
    Figueroa R; Maulik D
    Clin Obstet Gynecol; 2006 Jun; 49(2):308-19. PubMed ID: 16721109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for intrauterine growth restriction: current options and future directions.
    Pollack RN; Yaffe H; Divon MY
    Clin Obstet Gynecol; 1997 Dec; 40(4):824-42. PubMed ID: 9429797
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction.
    Tiralongo GM; Pisani I; Vasapollo B; Khalil A; Thilaganathan B; Valensise H
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):514-518. PubMed ID: 28295749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it time to replace iron folate supplements in pregnancy with multiple micronutrients?
    Bhutta ZA; Imdad A; Ramakrishnan U; Martorell R
    Paediatr Perinat Epidemiol; 2012 Jul; 26 Suppl 1():27-35. PubMed ID: 22742600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventing low birthweight through maternal multiple micronutrient supplementation: a cluster-randomized, controlled trial in Indramayu, West Java.
    Sunawang ; Utomo B; Hidayat A; Kusharisupeni ; Subarkah
    Food Nutr Bull; 2009 Dec; 30(4 Suppl):S488-95. PubMed ID: 20120790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative evaluation of multiple micronutrient and iron-folic acid supplementation during pregnancy in Pakistan: impact on pregnancy outcomes.
    Bhutta ZA; Rizvi A; Raza F; Hotwani S; Zaidi S; Moazzam Hossain S; Soofi S; Bhutta S
    Food Nutr Bull; 2009 Dec; 30(4 Suppl):S496-505. PubMed ID: 20120791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylaxis and treatment of foetal growth restriction.
    Nawathe A; David AL
    Best Pract Res Clin Obstet Gynaecol; 2018 May; 49():66-78. PubMed ID: 29656983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of fetal growth restriction: an evidence-based approach.
    Maulik D
    Clin Obstet Gynecol; 2006 Jun; 49(2):320-34. PubMed ID: 16721110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Umbilical artery Doppler in the assessment of fetal growth restriction.
    Maulik D; Mundy D; Heitmann E; Maulik D
    Clin Perinatol; 2011 Mar; 38(1):65-82, vi. PubMed ID: 21353090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy.
    McCowan LM; Figueras F; Anderson NH
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S855-S868. PubMed ID: 29422214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequacy of prenatal care as a major determinant of folic acid, iron, and vitamin intake during pregnancy.
    Lunet N; Rodrigues T; Correia S; Barros H
    Cad Saude Publica; 2008 May; 24(5):1151-7. PubMed ID: 18461244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
    Roberge S; Nicolaides K; Demers S; Hyett J; Chaillet N; Bujold E
    Am J Obstet Gynecol; 2017 Feb; 216(2):110-120.e6. PubMed ID: 27640943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil During Pregnancy: A Preclinical Meta-Analysis on Fetal Growth and Maternal Blood Pressure.
    Paauw ND; Terstappen F; Ganzevoort W; Joles JA; Gremmels H; Lely AT
    Hypertension; 2017 Nov; 70(5):998-1006. PubMed ID: 28893896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
    Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
    Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-medical prevention of pre-eclampsia.
    Ehrenberg A
    Acta Obstet Gynecol Scand Suppl; 1997; 164():108-10. PubMed ID: 9225653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the impact of dietary intakes in human pregnancy on infant birthweight.
    Grieger JA; Clifton VL
    Nutrients; 2014 Dec; 7(1):153-78. PubMed ID: 25551251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fetal growth retardation: prevention. Review of the literature].
    Boulot P; Giacalone PL; Hedon B; Laffargue F; Viala JL
    J Gynecol Obstet Biol Reprod (Paris); 1992; 21(8):857-67. PubMed ID: 1283397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal nutrient supplementation for suspected impaired fetal growth.
    Gülmezoglu AM; Hofmeyr GJ
    Cochrane Database Syst Rev; 2000; 2003(2):CD000148. PubMed ID: 10796156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.